573results about How to "Reduce weight loss" patented technology

Use of a growth hormone protein and polynucleotides encoding same comprising an amino-terminal carboxy-terminal peptide (CTP) of chorionic gonadotrophin and two carboxy-terminal chorionic gonadotrophin CTPs attached to the growth hormone in methods of inducing growth or weight gain, method of increasing insulin-like growth factor (IGF-1) levels, and methods of reducing the dosing frequency of a growth hormone in a human subject are disclosed. Pharmaceutical compositions comprising the growth hormone and polynucleotides encoding the growth hormone of the invention and methods of using same are also disclosed.

The invention discloses a low-density, high-rigidity and high-tenacity polypropylene nano composite material and a preparation method thereof. The low-density, high-rigidity and high-tenacity polypropylene nano composite material consists of the following raw materials in percentage by weight: 55 to 98 percent of polypropylene, 1 to 15 percent of organic clay, 0 to 30 percent of inorganic filler, 0.1 to 10 percent of compatilizer, 0 to 20 percent of toughening agent, 0.2 to 2 percent of stabilizing agent, and 0 to 5 percent of other additives. The low-density, high-rigidity and high-tenacity polypropylene nano composite material and the preparation method have the following advantages that: 1, the density and the weight of a product are reduced for the help of reducing the weight and the energy consumption of a finished product; 2, the rigidity and the tenacity are higher; 3, the process flow is simplified and the production cost is reduced effectively; and 4, the influences on the cutting of nano clay and the dispersion process caused by other components are avoided to the utmost extent to further improve the performance of the composite material.

The present invention discloses fusion proteins of the immunodominant antigens ESAT-6 and Ag85B from Mycobacterium tuberculosis or homologues thereof, and a tuberculosis vaccine based on the fusion proteins, which vaccine induces efficient immunological memory.

Provided herein are methods, kits, and pharmaceutical compositions that include a PI3 kinase inhibitor for treating lupus, a fibrotic condition, or inflammatory myopathies and other conditions (e.g., skin conditions).

The present invention is directed to the use of ibudilast for treating addictions, including drug and behavioral addictions. In particular, ibudilast is used to diminish the dopamine-mediated reward associated with addictions and to treat withdrawal syndromes after discontinuance of addictive drug use or behavior.

The invention relates to methods and compounds for treating chemotherapy-induced anemia. In particular, methods for treating chemotherapy-induced anemia in subjects refractory to treatment with recombinant human erythropoietin are encompassed herein.

The invention discloses a neodymium iron boron magnet made of neodymium iron boron nickel-plating waste materials in a sintered mode. The neodymium iron boron magnet resolves the problems that a neodymium iron boron magnet in the prior art is low in performance, low in utilizing rate of the waste materials and the like. The neodymium iron boron magnet is made of mixed materials through a sintering process, wherein the mixed materials are formed by the neodymium iron boron magnet nickel-plating waste materials and rich rare-earth compound material. For the neodymium iron boron magnet, residual magnetism (Br) of is greater than or equal to 1.2T, intrinsic coercive force (Hcj) is greater than or equal to 13.3 KOe, coercive force (Hcb) is greater than or equal to 11.6 KOe, the magnetic energy product (BH(max)) is greater than or equal to 34.8 MGOe, squareness (HK / Hcj) ranges from 0.97 to 0.98, the weight loss ratio is 0.19-1.10 mg / cm<2>, and the Br temperature coefficient is negative 0.090- negative 0.11% DEG C. The preparation method of the neodymium iron boron magnet comprises roasting the neodymium iron boron nickel-plating waste materials; manufacturing neodymium iron boron nickel-plating waste material powder; preparing the mixed materials; moulding in a compressed mode; and sintering. The preparation method is simple, effective, environment-friendly and low in cost.

The invention provides epoxy and oxetane compositions including the novel acyloxy and N-acyl curing agents described herein. Use of invention curing agents result in cured adhesive compositions with remarkably increased adhesion and reduced hydrophilicity when compared to resins cured with other types of curing agents. Furthermore, the curatives of this invention do not interfere with free-radical cure and are thus suited for use in hybrid cure thermoset compositions.

The invention discloses a high-performance polypropylene nano composite material and a preparation method thereof, and belongs to the field of polymer modification and processing. The high-performance polypropylene nano composite material comprises the components in percent by weight: 39 to 98% of polypropylene, 1 to 15% organic clay, 0 to 30% of inorganic filling material, 0.1 to 6% of compatilizer, 0 to 20% of flexibilizer, 0.2 to 2% of stabilizer, and 0 to 4% of other additive. Through the cooperative modification of nanoscale organic clay and micron-sized talcum powder to polypropylene, a nano composite material with higher rigidity, higher tenacity and other performance is obtained at a lower material density.

The present invention discloses composition and methods for reducing the weight loss and / or preserving the natural gloss of post-harvest edible plant matter. In particular, the methods comprising applying to the surface of the plant matter a composition comprising an edible wax having a melting temperature below 70° C.; a hydrocolloid; a fatty acid; an emulsifier; and water, wherein said edible wax is present in a weight percent ranging from about 10% to about 25% of the total weight of the composition.

A fire resistant polymeric composition which forms a target mineral on firing of the polymeric composition including 20-60 wt % of an organic polymer; 2-30 wt % of a magnesium compound that oxidises to form MgO; and 5 to 30 wt % silica. The composition preferably includes an alkaline earth metal borosilicate compound, the alkaline earth metal borosilicate compound forming a ceramic composition at an elevated temperature.

The invention relates to a high-boron iron-based wear-resistant surfacing flux-cored welding wire. The welding wire is composed of a low-carbon steel sheath and a core powder. It is characterized in that the iron element in the low-carbon steel sheath and the core powder are contained in the core powder. Elements include boron, carbon, manganese, and silicon. The weight percentage of boron, carbon, manganese, and silicon in the core powder of the welding wire is: boron 6 to 12%, carbon 0.1 to 3%, manganese 0.6 to 2%, silicon 0.3~1.5%, the balance is iron. It can also include Ti0.3~3.5%, Mn 0.6~2%, Si0.3~1.5%, molybdenum 0~1%, K / Na modifier 0~1%, and aluminum-magnesium alloy 0~1.5%. The high boron iron-based wear-resistant cladding flux-cored welding wire of the present invention mainly relies on boron, titanium, carbon and other alloying elements to form boride and a small amount of carbide to achieve the wear resistance of the cladding alloy, and by adding rare earth, nickel, Aluminum-magnesium alloys, etc. improve the overall performance of cladding alloys.

The composite fixed 76-83 deg C phase change material and its preparation belongs to the field of phase change heat accumulating material technology. The present invention has SEBS of smelting point 76-81.6 deg C as the packing and oil absorbing material and paraffin of phase change latent heat 200-220 kJ / kg as main energy storing material, and consists of paraffin in 66-80 wt%, high density polyethylene in 11-15 wt%, SEBS in 4-12 wt% and expanded graphite in 3-7 wt%. The composite phase change material is prepared through smelting paraffin in a reactor, adding and smelting high density polyethylene and SEBS, adding expanded graphite and mixing homogeneously, molding at 200-300 KPa pressure to form plate, cooling and demoulding. The material may be set directly inside boiler to contact water as heat transferring medium, and after soaking in hot water in temperature above the smelting point for 200 hr, it has weight loss less than 2 % and phase change latent heat change less than 10 %.

A method is provided for visualizing programs for cooking devices, in which after at least one program has been selected from a plurality of programs, the selected program is shown on at least one display device in the form of at least one program representative, wherein each program representative comprises a virtual token. Also a cooking device is provided for the method.

Methods and pharmaceutical compositions for preconditioning and / or providing neuroprotection to the animal central nervous system against the effects of ischemia, trauma, metal poisoning and neurodegeneration, including the associated cognitive, behavioral and physical impairments. In one embodiment, the method is accomplished by stimulating and stabilizing hypoxia-inducible factor-1α (HIF-1α). HIF-1α is known to provide a neuroprotective benefit under ischemic conditions. Patients at risk for certain diseases or disorders that are associated with risk for cerebral ischemia may benefit, e.g., those at risk for Alzheimer's disease, Parkinson's disease, Wilson's disease or stroke or those patients having head or spinal cord injury. Patients undergoing certain medical procedures that may result in ischemia may also benefit. Initially, the possibility of ischemia or neurodegeneration is recognized. Intranasal therapeutic agents are administered to the upper third of the nasal cavity to bypass the blood-brain barrier and access the central nervous system directly to avoid unwanted and potentially lethal side effects. Therapeutic agents include those substances that interact with iron and / or copper such as iron chelators, copper chelators, and antioxidants. A particular example of such therapeutic agents is the iron chelator deferoxamine (DFO). Intranasal administration of DFO is known to stimulate and / or stabilize HIF-1α and provides an efficient and safe method for pre-conditioning the brain to protect against cerebral ischemia. Moreover, DFO is shown to decrease weight loss in subjects when administered pre and / or post stroke.

The invention belongs to the technical field of food deep processing and particularly relates to a low sugar high dietary fiber composite fruit and vegetable paste and a preparation method thereof. Fruits and vegetables subjected to sugaring, acidity regulators, thickening agents, coloring matters and essence are subjected to scalding treatment, pulping, blending, concentrating, homogenizing, canning and sterilization to form the composite fruit and vegetable paste, the mass content of soluble solids is in a range from 26% to 31%, and the mass content of total sugar is in a range from 35.23% to 39.53%. According to the low sugar high dietary fiber composite fruit and vegetable paste and the preparation method thereof, the fruits and vegetables subjected to sugaring are used as main raw materials, the use ratio of the raw materials is improved, the production costs are lowered, types of jams are enriched, the preparation method is simple, the operation is simple, convenient and easy to control, the prepared composite fruit and vegetable paste has comprehensive nutritions, low sugar and high dietary fiber, health care and edible effects are integrated, the effect of balancing human nutrition can be achieved, simultaneously the taste is good, the low sugar high dietary fiber composite fruit and vegetable paste has low price and fine quality, the process is simple, the cost is low, the environment is not polluted, and the industrialized production is facilitated.

The invention provides a smoke-free polishing treatment solution for a high-gloss aluminum sectional material and a use method thereof. The smoke-free polishing treatment solution is characterized by comprising 85% H3PO4, 98% H2SO4, 30% hydrogen peroxide or potassium permanganate or perchloric acid or sodium molybdate or ammonium persulfate or sodium vanadate, cerium nitrate or sodium silicate, imidazoline or benzotriazole or phytic acid or thiourea, sodium dodecyl benzene sulfonate or sodium benzene sulfonate or sodium toluene sulfonate or sodium xylene sulfonate, and nickel chloride or nickel sulfate or lead acetate. Compared with the prior art, the smoke-free polishing treatment solution provided by the invention has advantage of no generation of high-pollution NOx yellow smoke, and enables the surface of the aluminum sectional material to have excellent gloss and no pitting microscopic defects.

The present invention relates to a dopamine D3 receptor portion excitant or its pharmaceutically acceptable salt and its application for curing diseases of central nervous system. Said invention also provides its chemical structure general formula, and provides detailed description.

A fluoroelastomer composition comprising a) a fluoroelastomer, b) a curative and c) barium sulfate having an average particle size less than 200 nm is disclosed. This composition loses less weight and produces fewer particles when exposed to reactive plasmas than do similar compositions which contain larger particle size barium sulfate.

A composition comprising chromium and insulin and / or a chromium-insulin complex, its method of preparation, and its use in the prevention and treatment of hypoglycemia and hypoglycemia-related conditions. This composition can be administered in numerous ways, including parenterally, intranasally, and orally. The composition stabilizes serum glucose levels and has a synergistic effect compared to chromium and insulin administered separately.

The present invention is based on the identification and characterization of a number of novel M. tuberculosis derived proteins and protein fragments. The invention is directed to the polypeptides and immunologically active fragments thereof, the genes encoding them, immunological compositions such as vaccines and skin test reagents containing the polypeptides.

The invention relates to an NdFeB magnet formed by sintering NdFeB recycling waste and a preparation method of the NdFeB magnet, and belongs to the technical field of a rare earth magnetic material. The NdFeB magnet is formed by a mixed material formed by the recycling waste and a prepared material by a sintering technology, and the mass percentages of the recycling waste and the prepared material are respectively 2%-50% and 50%-98%; the recycling waste is RxMyBzFe(1-x-y-z) (x=29%-32%, y=0-4% and z=0.9%-1.1%), the prepared material is RxMyBzFe(1-x-y-z) (x=29%-35%, y=0-4% and z=0.9%-1.1%), R is one or more elements selected from La, Ce, Pr, Nd, Gd, Ho and Dy, and M is one of more elements selected form Co, Al, Cu, Nb, Zr and Ga. According to the NdFeB magnet and the preparation method, disclosed by the invention, the comprehensive utilization rate and the preparation efficiency of the recycling waste are increased, and the production cost is reduced.

The present invention relates to the use of polyene fungicides for reducing weight loss of crops.

The invention discloses a preservation method for bamboo shoots. The method includes the steps that 1, ultrasonic cleaning is carried out; 2, the bamboo shoots are soaked in a preservation solution, wherein the preservation solution is prepared from, by weight, 10-20 parts of aloe extract liquor, 10-15 parts of honeysuckle flower extract liquor, 3-5 parts of vitamin E, 5-10 parts of chitosan and 10-20 parts of water; 3, ultraviolet radiation is carried out; 4, heat shock treatment is carried out; 5, cooling and non-sealed packaging are carried out; 6, the bamboo shoots are put into an air-conditioned cold store with the temperature of 8-10 DEG C and stored for 1-3 h, and then the temperature of the air-conditioned cold store is regulated to be 2-5 DEG C to continue cold storage. By means of the preservation method for the bamboo shoots, browning, ageing and mildewing of the bamboo shoots can be effectively prevented, the weight loss ratio and rot index of the bamboo shoots can be reduced, the preservation time of the bamboo shoots can be prolonged, the loss of nutritional ingredients can be reduced, the flavor and quality of the bamboo shoots can be guaranteed, and safety and high efficiency can be achieved.

The invention provides a catalyst for use in synthesis of dioctyl terephthalate and a method for preparing dioctyl terephthalate by applying the catalyst. The catalyst consists of a catalyst 1 and a catalyst 2, wherein the catalyst 1 consists of an ionic liquid and a metal compound; the catalyst 2 consists of a titanium metal compound and other metal compound; the positive ion of the ionic liquid are an imidazole ion or a benzimidazole ion; the negative ion of the ionic liquid is a bisulfate ion; or the positive ion of the ionic liquid is a benzimidazole ion or an imidazole ion with one or two sulfonic acid radicals; the titanium metal compound is selected from at least one compound of tetrabutyl titanate, isopentyl ester titanate, isopropyl titanate or titanium dioxide; and the other compound is selected from at least one compound of dibutyldimethoxytin, dibutyltin oxide, monooctyl ester stannite, zinc acetate and cobalt acetate. Due to the adoption of the technical scheme provided by the invention, the cost can be reduced, the reaction speed is increased, energy consumption is lowered, and the quality of an obtained product is high.

Use of a growth hormone protein and polynucleotides encoding same comprising an amino-terminal carboxy-terminal peptide (CTP) of chorionic gonadotrophin and two carboxy-terminal chorionic gonadotrophin CTPs attached to the growth hormone in methods of inducing weight loss or body fat reduction, methods of increasing insulin-like growth factor (IGF-1) levels, and methods of reducing the dosing frequency of a growth hormone in a human subject are disclosed. Pharmaceutical compositions comprising the growth hormone and polynucleotides encoding the growth hormone of the invention and methods of using same are also disclosed.

The invention discloses a method for immersing beef omasum. The method comprises the following steps of: firstly, cleaning salted beef omasum, boiling in boiled water for 3-10 minutes, and draining to obtain preprocessed beef omasum; secondly, adding the preprocessed beef omasum into alkaline liquor with the pH value more than 12, immersing for 10-70 minutes at the temperature of 10-35 DEG C, washing by clean water until the pH value is 11-11.5, immersing the beef omasum into composite phosphate with the pH value of 8.5-9.0, and performing water retention for 8-15 hours to obtain water-retention beef omasum; finally, adding the water-retention beef omasum into 0.001wt%-0.02wt% of a sucrose fatty acid ester solution for retaining the freshness to obtain the immersed beef omasum. The method is simple, high in weight gain rate, low in water loss and long in storage time, the quality guarantee period of the immersed beef omasum can reach more than 20 days under refrigeration conditions of 0-4 DEG C, and the prepared beef omasum is crisp, tender and dissolvable in mouth feel, can not become tough after being cooked for a long time, and has a good development value.

The invention provides for a method of treating inappetance-induced weight loss in one or more companion animals or livestock. The method provides for administering a therapeutically effective amount of a capromorelin-containing composition to the companion animal or livestock. Optionally, one or more flavoring agents or flavor-masking agents can be added to the capromorelin-containing composition to enhance or mask the flavoring of the composition for the companion animal or livestock.

The present invention discloses compounds of Formula I: (I) having 11beta-HSD type 1 antagonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula I, as well as the use of the Fomula I and compositions as medicaments to treat diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, Syndrome X, and other conditions associated with hyperglycemia.